[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1039802T3 - Transdermal terapeutisk anordning med capsicin og capsaicinanaloger - Google Patents

Transdermal terapeutisk anordning med capsicin og capsaicinanaloger

Info

Publication number
DK1039802T3
DK1039802T3 DK98962908T DK98962908T DK1039802T3 DK 1039802 T3 DK1039802 T3 DK 1039802T3 DK 98962908 T DK98962908 T DK 98962908T DK 98962908 T DK98962908 T DK 98962908T DK 1039802 T3 DK1039802 T3 DK 1039802T3
Authority
DK
Denmark
Prior art keywords
capsaicin
capsicin
therapeutic device
transdermal therapeutic
capsaicin analogues
Prior art date
Application number
DK98962908T
Other languages
English (en)
Inventor
Wendye R Robbins
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of DK1039802T3 publication Critical patent/DK1039802T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
DK98962908T 1997-12-15 1998-12-08 Transdermal terapeutisk anordning med capsicin og capsaicinanaloger DK1039802T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/990,633 US6239180B1 (en) 1995-11-08 1997-12-15 Transdermal therapeutic device and method with capsaicin and capsaicin analogs
PCT/US1998/025794 WO1999030560A1 (en) 1997-12-15 1998-12-08 Transdermal therapeutic device and method with capsaicin and capsaicin analogs

Publications (1)

Publication Number Publication Date
DK1039802T3 true DK1039802T3 (da) 2003-09-22

Family

ID=25536360

Family Applications (2)

Application Number Title Priority Date Filing Date
DK03005137T DK1316308T3 (da) 1997-12-15 1998-12-08 Transdermalt terapeutisk plaster med capsaicin og capsaicin-analoger
DK98962908T DK1039802T3 (da) 1997-12-15 1998-12-08 Transdermal terapeutisk anordning med capsicin og capsaicinanaloger

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK03005137T DK1316308T3 (da) 1997-12-15 1998-12-08 Transdermalt terapeutisk plaster med capsaicin og capsaicin-analoger

Country Status (11)

Country Link
US (2) US6239180B1 (da)
EP (2) EP1039802B1 (da)
AT (2) ATE344023T1 (da)
CA (1) CA2314326C (da)
CY (1) CY1107582T1 (da)
DE (2) DE69814917T2 (da)
DK (2) DK1316308T3 (da)
ES (2) ES2272827T3 (da)
HK (1) HK1030853A1 (da)
PT (1) PT1039802E (da)
WO (1) WO1999030560A1 (da)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239180B1 (en) * 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
US6383511B1 (en) * 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
GB2355934B (en) * 1999-11-05 2003-11-05 Lohmann Gmbh & Co Kg Wound dressing
AUPQ622600A0 (en) * 2000-03-15 2000-04-06 Unisearch Limited Treatment and/or prevention of ocular pain
DE10056009A1 (de) * 2000-11-11 2002-05-16 Beiersdorf Ag Hautfreundliches Wirkstoffpflaster zur transdermalen Verabreichung hyperämisierender Wirkstoffe
WO2003015698A2 (en) * 2001-08-13 2003-02-27 University Of Pittsburgh Application of lipid vehicles and use for drug delivery
US8110217B2 (en) * 2001-08-13 2012-02-07 University Of Pittsburgh Sphingomyelin liposomes for the treatment of hyperactive bladder disorders
EP1450824A4 (en) * 2001-11-02 2005-09-28 Elan Corp Plc PHARMACEUTICAL COMPOSITION
EP1539124B1 (en) 2002-09-05 2018-07-18 Vanderbilt Royalty Sub L.P. Compositions and kits for the removal of irritating compounds from bodily surfaces
CA2499994C (en) * 2002-09-23 2012-07-10 Verion, Inc. Abuse-resistant pharmaceutical compositions
US7687080B2 (en) * 2002-11-25 2010-03-30 Taraxos Inc. Treatment of neuropathy
JP2006513267A (ja) 2002-12-18 2006-04-20 アルゴルクス ファーマスーティカルズ，インク カプサイシノイドの投与
US20040191338A1 (en) * 2002-12-18 2004-09-30 Algorx Administration of capsaicinoids
US7235270B2 (en) 2003-03-10 2007-06-26 Mayeux Jerry V Pain balm
EP1615880A4 (en) * 2003-04-08 2007-03-07 Algorx Pharmaceuticals Inc PREPARATION AND CLEANING OF SYNTHETIC TRANS CAPSAICIN
EP1610742B1 (en) * 2003-04-10 2015-01-21 Neurogesx, Inc. Uses and compositions for administration of capsaicin
RU2349315C9 (ru) * 2003-04-14 2010-02-27 Лтс Ломанн Терапи-Системе Аг Терапевтический пластырь с полисилоксановой матрицей, содержащей капсаицин
DE102004009904A1 (de) * 2004-02-26 2005-09-22 Grünenthal GmbH Kit aus einem gegebenenfalls wirkstoffhaltigen Pflaster und einem Hautirritationen verhindernden Mittel
WO2005117981A1 (en) * 2004-06-02 2005-12-15 Sri International Formulations comprising a capsaicinoid a local anesthetic and/or an antipruritic agent for the treatment of pain
US7704522B2 (en) 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
CN101119713A (zh) * 2004-11-24 2008-02-06 阿尔高克斯制药公司 类辣椒素凝胶制剂及其用途
JP2006206471A (ja) * 2005-01-26 2006-08-10 Nitto Denko Corp テープ製剤
US20060204561A1 (en) * 2005-02-14 2006-09-14 Naweed Muhammad Device for delivery of TRPV1 agonists
US20060210613A1 (en) * 2005-03-15 2006-09-21 Carliss Richard D Therapeutic wound care product
EP1865933B1 (en) * 2005-03-30 2015-11-04 Vanderbilt Royalty Sub L.P. Low-concentration capsaicin patch and methods for treating neuropathic pain
EP1865941B8 (en) * 2005-04-01 2010-12-22 Neurogesx, Inc. Oils of capsaicinoids and methods of making and using the same
US7282224B1 (en) 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
US7943666B2 (en) * 2006-07-24 2011-05-17 Trinity Laboratories, Inc. Esters of capsaicin for treating pain
US7645767B2 (en) * 2006-08-31 2010-01-12 Trinity Laboratories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
US20080107747A1 (en) * 2006-10-23 2008-05-08 Roederer Joy E Pain relief composition
EP2276420B1 (en) 2008-04-04 2021-10-06 Journey1, Inc. Device to treat an eye having an epithelium with a defect
US8987328B2 (en) * 2008-10-30 2015-03-24 Trinity Laboratories, Inc. Esters of capsaicinoids as dietary supplements
US8591025B1 (en) 2012-09-11 2013-11-26 Nexisvision, Inc. Eye covering and refractive correction methods for LASIK and other applications
NO2490635T3 (da) 2009-10-23 2018-02-03
WO2011050365A1 (en) 2009-10-23 2011-04-28 Forsight Labs, Llc Conformable therapeutic shield for vision and pain
AU2011323743B2 (en) 2010-10-25 2016-01-28 Nexisvision, Inc. Methods and apparatus to identify eye coverings for vision
US12044905B2 (en) 2011-04-28 2024-07-23 Journey1 Inc Contact lenses for refractive correction
US9423632B2 (en) 2012-04-20 2016-08-23 Nexisvision, Inc. Contact lenses for refractive correction
CA2834295A1 (en) 2011-04-28 2012-11-01 Nexisvision, Inc. Eye covering and refractive correction methods and apparatus having improved tear flow, comfort, and/or applicability
BR112014005358A8 (pt) 2011-09-09 2017-10-03 Propella Therapeutics Inc Composições compreendendo agonista seletivo de trpv1 e seus usos
US9465233B2 (en) 2012-04-20 2016-10-11 Nexisvision, Inc. Bimodular contact lenses
ES2797624T3 (es) 2012-05-23 2020-12-03 Cellix Bio Private Ltd Composición para el tratamiento de la enfermedad inflamatoria intestinal
CA2873098A1 (en) 2012-05-23 2013-11-28 Cellixbio Private Limited Compositions and methods for the treatment of multiple sclerosis
JP6310072B2 (ja) 2013-06-26 2018-04-11 ネクシスビジョン， インコーポレイテッド 屈折矯正のためのコンタクトレンズ
US9341864B2 (en) 2013-11-15 2016-05-17 Nexisvision, Inc. Contact lenses having a reinforcing scaffold
WO2015116559A1 (en) 2014-01-29 2015-08-06 Nexisvision, Inc. Multifocal bimodulus contact lenses
BR112016023815A2 (pt) 2014-04-15 2017-08-15 Vizuri Health Sciences Llc composições tópicas para o alívio da dor, produção e uso
WO2016046835A1 (en) 2014-09-26 2016-03-31 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy and neurological disorders
AU2014407862B2 (en) 2014-09-29 2020-03-26 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
WO2016067297A1 (en) 2014-10-27 2016-05-06 Cellix Bio Private Limited Salts of valproic acid with piperazine, ethylenediamine, lysine and/or eicosapentaenoic ecid (epa) amine derivatives for the treatment of epilepsy
SG11201703369WA (en) 2014-10-27 2017-05-30 Cellix Bio Private Ltd Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
AU2015356569A1 (en) 2014-12-01 2017-06-29 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
CA2976187A1 (en) 2015-02-09 2016-08-18 Cellix Bio Private Limited Benzydamine salts and compositions thereof useful for the treatment of mucositis
US10898537B2 (en) 2015-07-31 2021-01-26 Delivra Inc. Transdermal formulations for delivery of capsaicinoids
SG11201900588YA (en) 2016-08-11 2019-02-27 Cellix Bio Private Ltd Compositions and methods for the treatment of irritable bowel syndrome
CN110099681A (zh) 2016-10-04 2019-08-06 塞尔利克斯生物私人有限公司 用于治疗口腔干燥症的组合物和方法
WO2018115984A1 (en) 2016-12-19 2018-06-28 Cellix Bio Private Limited Compositions and methods for the treatment of inflammation
CN111093704A (zh) 2017-07-27 2020-05-01 阿勒根公司 用于减少身体脂肪的前列环素受体激动剂
SG11202004019SA (en) 2017-11-17 2020-05-28 Cellix Bio Private Ltd Compositions and methods for the treatment of eye disorders
WO2019097381A1 (en) 2017-11-17 2019-05-23 Cellix Bio Private Limited Compounds, compositions and methods for treatment of eye disorders and skin diseases
EP4121027A1 (en) 2020-03-17 2023-01-25 Grünenthal GmbH Repeated topical application of capsaicin patch for treating initial non-responders
AU2021249486A1 (en) 2020-04-03 2022-12-08 Grünenthal GmbH Regimen for repeated topical application of capsaicin patch
RU2755206C1 (ru) 2020-05-20 2021-09-14 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Средство пролонгированного анальгетического действия и лекарственный препарат на его основе
US11234947B2 (en) * 2020-06-30 2022-02-01 Imperial College Innovations Limited Treatment of peripheral neuropathy induced by cancer chemotherapy

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486450B1 (en) 1980-07-14 1998-07-28 Joel E Bernstein Method of treating psoriatic skin and composition
US4313958A (en) 1980-10-24 1982-02-02 The Procter & Gamble Company Method of producing analgesia
US4424205A (en) 1982-03-18 1984-01-03 The Procter & Gamble Company Hydroxyphenylacetamides having analgesic and anti-irritant activity
US4536404A (en) 1983-06-16 1985-08-20 Dermatological Enterprises, Ltd. Method and composition for treating post-herpetic neuralgia
US4544669A (en) 1983-07-14 1985-10-01 The Procter & Gamble Company Compounds and compositions useful for producing analgesia
US4532139A (en) 1983-07-14 1985-07-30 The Procter & Gamble Company Compounds and compositions useful for producing analgesia
US4544668A (en) 1983-07-14 1985-10-01 The Procter & Gamble Company Compounds and compositions useful for producing analgesia
US4592912A (en) 1983-10-31 1986-06-03 Harriet Nickolaus Ache and pain relieving and preventing composition
US4681897A (en) 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US4898887A (en) * 1984-12-20 1990-02-06 The Procter & Gamble Company Compounds and compositions having anti-inflammatory and analgesic activity
US4971800A (en) 1988-07-08 1990-11-20 The Regents Of The University Of California Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents
US4939149A (en) 1988-10-24 1990-07-03 The United States Of America As Represented By The Department Of Health And Human Services Resiniferatoxin and analogues thereof to cause sensory afferent C-fiber and thermoregulatory desensitization
US4997853A (en) 1988-12-02 1991-03-05 Galenpharma, Inc. Method and compositions utilizing capsaicin as an external analgesic
CA1338779C (en) 1989-03-17 1996-12-10 Harry Hind Method for treating pain associated with herpes-zoster and post-herpetic neuralgia by topical application of local anesthetics
US5411738A (en) 1989-03-17 1995-05-02 Hind Health Care, Inc. Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
AU5744490A (en) 1989-05-15 1990-12-18 Afferon Corporation Composition and method for neural desensitization
US5063060A (en) 1989-12-19 1991-11-05 Cisco Limited Partnership Compositions and method for treating painful, inflammatory or allergic disorders
JP2748199B2 (ja) * 1991-08-27 1998-05-06 泰一郎 岩倉 気管支喘息発作の予防と治療貼付剤
US5260313A (en) 1992-03-12 1993-11-09 National Pain Institute, Inc. Diagnosis and treatment of various neuralgias
US5431914A (en) 1992-04-17 1995-07-11 Adekunle; Michael Method of treating an internal condition by external application of capsaicin without the need for systemic absorption
JP3414423B2 (ja) * 1992-11-27 2003-06-09 積水化学工業株式会社 眠気防止用外用剤及び貼付剤
US5665360A (en) 1993-05-14 1997-09-09 Mann; Richard H. Method of treating peripheral neuropathies of the feet and legs
US5910512A (en) 1994-04-18 1999-06-08 Healthline Laboratories, Inc. Topical analgesic using water soluble capsaicin
DE4414502A1 (de) * 1994-04-26 1995-11-02 Edda Scholten Salbe zur äußerlichen Anwendung bei Schmerzen
US5665378A (en) 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
US5762963A (en) 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
US5788982A (en) 1995-06-16 1998-08-04 Nadoolman; Wolffe Method and composition for treating oral pain using capsaicin
US6239180B1 (en) * 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
US5869533A (en) 1996-04-23 1999-02-09 Holt; Stephen D. Non-irritating capsaicin formulations and applicators therefor
US5854291A (en) 1996-04-23 1998-12-29 Medical Merchandising, Inc. Pain reliever and method of use
US5856361A (en) 1996-04-23 1999-01-05 Medical Merchandising, Inc. Pain reliever and method of use
DK1201241T3 (da) 1997-03-13 2010-12-13 James N Campbell Sammensætninger indeholdende capsaicin eller capsaicinanaloge og et bedøvelsesmiddel
CA2309903C (en) 1998-01-22 2012-03-27 The Regents Of The University Of California Nucleic acid sequences encoding capsaicin receptor
KR100703640B1 (ko) 1998-02-24 2007-04-05 웨이크 포리스트 유니버시티 만성 통증 및 여성에 특유한 통증을 비롯한 통증의 치료 방법

Also Published As

Publication number Publication date
ES2272827T3 (es) 2007-05-01
DE69814917T2 (de) 2004-02-12
EP1039802A4 (en) 2002-01-23
US6239180B1 (en) 2001-05-29
CA2314326C (en) 2008-11-18
EP1316308B1 (en) 2006-11-02
US20010002406A1 (en) 2001-05-31
EP1039802B1 (en) 2003-05-21
ATE240723T1 (de) 2003-06-15
DE69836352T2 (de) 2007-05-24
WO1999030560A1 (en) 1999-06-24
CA2314326A1 (en) 1999-06-24
ATE344023T1 (de) 2006-11-15
DK1316308T3 (da) 2007-03-05
HK1030853A1 (en) 2001-05-25
CY1107582T1 (el) 2013-03-13
DE69836352D1 (de) 2006-12-14
EP1039802A1 (en) 2000-10-04
EP1316308A1 (en) 2003-06-04
PT1039802E (pt) 2003-10-31
ES2196640T3 (es) 2003-12-16
DE69814917D1 (de) 2003-06-26

Similar Documents

Publication Publication Date Title
DK1039802T3 (da) Transdermal terapeutisk anordning med capsicin og capsaicinanaloger
DK1201241T3 (da) Sammensætninger indeholdende capsaicin eller capsaicinanaloge og et bedøvelsesmiddel
GEP20002146B (en) Therapeutic Peptide Derivatives
DK0480934T3 (da) Lægemiddel, der indeholder ephedrin og koffein til behandling af overvægt
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
DE69213814D1 (de) Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
DE69625682D1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
NO995944L (no) Anti-arrytmisk blanding og fremgangsmåter for behandling
ATE126061T1 (de) Verwendung von lithium zur behandlung oder prophylaxe von molluscum contagiusum.
ATE200617T1 (de) Pharmazeutische zusammensetzungen zur transdermalen verabreichung von melatonin und/oder seine analoge
MX9700967A (es) Uso terapeutico de acetazolamida para el tratamiento de edema cerebral.
CY1108368T1 (el) Διαδερμικη συσκευη φελοδιπινης και μεθοδοι
NO960866L (no) Fremgangsmåte til behandling av leversykdom og lignende indikasjoner med vasodilaterende midler
RU95122262A (ru) Способ лечения повреждений периферических нервов при травмах конечностей
UA28769A (uk) Спосіб лікування променевих ушкоджень шкіри
UA32384A (uk) Спосіб лікування пародонтиту